drugset / Trial / NCT06273020
Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke
Phase 4
Unknown
60 enrolled
Hospital Universitario Dr. Jose E. Gonzalez
Ever Neuro Pharma GmbH · collab
RandomizedParallel-groupOpen-labelSupportive care
Summary
A prospective, single-center study would be carried out in the Neurology Department of the University Hospital "Dr. José Eleuterio González" in order to analyze the effect of cerebrolysin on the blood-brain-barrier in patients with ischemic stroke with personal history of type-2 diabetes
Timeline
- Start
- 2022-11-17
- Primary completion
- 2024-11
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cerebrolysin | Peptide | 30 ml | — |